Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Monograph Capital Holdings Advisors, LLC - 05 Jun 2025 SCHEDULE 13D/A Report for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)
- Filing manager
- Monograph Capital Holdings Advisors, LLC
- Reporting owner
- Monograph Capital Partners I, L.P.
- Beneficially owned shares
- 838,615 shares
- Large-stake signal
-
Ownership
1.8%Beneficial ownership of this reported class.
Shares
838,615 sharesShares beneficially owned as disclosed.
Event date
05 Jun 2025Date tied to the ownership event or amendment.
Accepted by SEC
09 Jun 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 1.8%
- Symbol
- URGN
- Shares outstanding
- 46,589,722 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 09 Jun 2025, 19:19:46 UTC
- Event date
- 05 Jun 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Monograph Capital Holdings Advisors, LLC disclosed 1.8% ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN) on 05 Jun 2025.
Key facts
- Monograph Capital Holdings Advisors, LLC filed SCHEDULE 13D/A for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN).
- Disclosed ownership: 1.8%.
- Date of event: 05 Jun 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Jun 2025, 19:19.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (5)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Monograph Capital Partners I, L.P. | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta / Partner and Authorized Signatory | 0001864082 |
| Monograph Capital Partners I GenPar, LP | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta / Partner and Authorized Signatory | |
| Monograph Capital Holdings Advisors, LLC | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta / Partner and Authorized Signatory | 0001988760 |
| Fred Cohen | 1.9% | 838,615 | 15,000 | 838,615 | /s/ Michael LaGatta | Michael LaGatta/ Attorney-in-fact (1) | 0001339358 |
| Charles Conn | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta/ Attorney-in-fact (2) |
CIK / CUSIP context first